Lilly reports fourth-quarter and full-year 2014 results
Eli Lilly reported full-year 2014 revenue declined 15 percent to $19.6 billion versus revenue of $23.1 billion in 2013. Operating income in 2014 decreased 50 percent compared to 2013 to $2.660 billion. Full-year 2014 earnings per share totaled $2.23, or $2.78 (non-GAAP). January 30, 2015